A Single Oncogenic Enhancer Rearrangement Causes Concomitant EVI1 and GATA2 Deregulation in Leukemia

Gröschel, Stefan, Sanders, Mathijs A., Hoogenboezem, Remco, de Wit, Elzo, Bouwman, Britta A.M., Erpelinck, Claudia, van der Velden, Vincent H.J., Havermans, Marije +13 more·2014·Cell
DOI 10.1016/j.cell.2014.02.019

Cited by (693)

Items 301–400 of 693

  1. Super enhancers as master gene regulators in the pathogenesis of hematologic malignancies
    Sonia M. Debek, Przemysław Juszczyński · 2022 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  2. Enhancer RNAs (eRNAs) in Cancer: The Jacks of All Trades
    Sara Napoli, Nicolas Munz, Francesca Guidetti, Francesco Bertoni · 2022 · Cancers
  3. Regulation of 3D Organization and Its Role in Cancer Biology
    Anghui Peng, Wang Peng, Ruiqi Wang, Hao Zhao, Xinyang Yu, Yihao Sun · 2022 · Frontiers in Cell and Developmental Biology
  4. Panel-based RNA fusion sequencing improves diagnostics of pediatric acute myeloid leukemia
    Lina Marie Hoffmeister, Julia Suttorp, Christiane Walter, Evangelia Antoniou, Yvonne Lisa Behrens, Gudrun Göhring, Amani Awada, Nils v. Neuhoff, Dirk Reinhardt, Markus Schneider · 2023 · Leukemia
  5. Super-Enhancers and Their Parts: From Prediction Efforts to Pathognomonic Status
    Anastasia V. Vasileva, Marina G. Gladkova, German A. Ashniev, Ekaterina D. Osintseva, А. В. Орлов, Ekaterina V. Kravchuk, Anna Boldyreva, Alexandr G. Burenin, Petr Ivanovich Nikitin, Natalia N. Orlova · 2024 · International Journal of Molecular Sciences
  6. The role of EVI-1 in normal hematopoiesis and myeloid malignancies (Review)
    Xiaofen Yuan, Xidi Wang, Kehong Bi, Guosheng Jiang · 2015 · International Journal of Oncology
  7. The search for cis-regulatory driver mutations in cancer genomes
    Rebecca C. Poulos, Mathew A. Sloane, Luke B. Hesson, Jason W.H. Wong · 2015 · Oncotarget
  8. PDCD6 cooperates with C-Raf to facilitate colorectal cancer progression via Raf/MEK/ERK activation
    Xiaojuan Wang, Fan Wu, Han Wang, Xiaoyuan Duan, R. Stephanie Huang, Amannisa Tuersuntuoheti, Luying Su, Shida Yan, Yuechao Zhao, Yan Lü et al. · 2020 · Journal of Experimental & Clinical Cancer Research
  9. Identification of gene targets of mutant C/EBPα reveals a critical role for MSI2 in CEBPA-mutated AML
    Elizabeth C. Heyes, Luisa Schmidt, Gabriele Manhart, Thomas Eder, Ludovica Proietti, Florian Grebien · 2021 · Leukemia
  10. Cytogenetics of Acute Leukemia
    Nyla A. Heerema, Susana Catalina Raimondi · 2012 · Springer eBooks
  11. Lethal neonatal bone marrow failure syndrome with multiple congenital abnormalities, including limb defects, due to a constitutional deletion of 3′ MECOM
    Lars T. van der Veken, Merel C. Maiburg, Floris Groenendaal, Marielle E van Gijn, Andries C. Bloem, Claudia A. J. Erpelinck-Verschueren, Stefan Gröschel, Mathijs Arnoud Sanders, Ruud Delwel, Marc Bierings et al. · 2018 · Haematologica
  12. Reorganization of the 3D Genome Pinpoints Noncoding Drivers of Primary Prostate Tumors
    James R. Hawley, Stanley Zhou, Christopher Arlidge, Giacomo Grillo, Ken J. Kron, Rupert Hugh-White, Theodorus H. van der Kwast, Michael E. Fraser, Paul C. Boutros, Robert Glen Bristow et al. · 2021 · Cancer Research
  13. The Estrogen Receptor α-Cistrome Beyond Breast Cancer
    Marjolein Droog, Mark Mensink, Wilbert T. Zwart · 2016 · Molecular Endocrinology
  14. Immuno-oncology from the perspective of somatic evolution
    Santiago González, Nadezda V. Volkova, Philip A. Beer, Moritz Gerstung · 2017 · Seminars in Cancer Biology
  15. Chromatin topology reorganization and transcription repression by PML-RARα in acute promyeloid leukemia
    Ping Wang, Zhonghui Tang, Byoungkoo Lee, Jacqueline Jufen Zhu, Liuyang Cai, Przemysław Szałaj, Simon Zhongyuan Tian, Meizhen Zheng, Dariusz Plewczyński, Xiaoan Ruan et al. · 2020 · Genome biology
  16. Live-Cell Imaging Reveals Enhancer-dependent Sox2 Transcription in the Absence of Enhancer Proximity
    Jeffrey M. Alexander, Juan Guan, Bo Huang, Stavros Lomvardas, Orion David Weiner · 2018 · bioRxiv (Cold Spring Harbor Laboratory)
  17. Accurate prediction of boundaries of high resolution topologically associated domains (TADs) in fruit flies using deep learning
    John Henderson, Vi Ly, Shawn Olichwier, Pranik Chainani, Yu Liu, Benjamin Soibam · 2019 · Nucleic Acids Research
  18. Crosstalk between Hepatitis B Virus and the 3D Genome Structure
    Joao Diogo Dias, Nazim Sarica, Axel Cournac, Romain Koszul, Christine Neuveut · 2022 · Viruses
  19. 3q26.2/MECOM Rearrangements by Pericentric Inv(3): Diagnostic Challenges and Clinicopathologic Features
    Zhenya Tang, Wei Wang, Su Yang, Hanadi El Achi, Hong Fang, Karen Amelia Nahmod, Gökçe Törüner, Jie Xu, Beenu Thakral, Edward Ayoub et al. · 2023 · Cancers
  20. ALWAYS STRESSED BUT NEVER EXHAUSTED: HOW STEM CELLS IN MYELOID NEOPLASMS AVOID EXTINCTION IN INFLAMMATORY CONDITIONS
    Helong Zhao, Michael W. Deininger · 2023 · Blood
  21. Therapeutic targeting of leukemia stem cells in acute myeloid leukemia
    Karina Barbosa, A. Deshpande · 2023 · Frontiers in Oncology
  22. Cytogenetics and genomics of acute myeloid leukemia
    Oraine Snaith, Corey Poveda-Rogers, Dorottya I. Laczko, Guang Yang, Jennifer J. D. Morrissette · 2023 · Best Practice & Research Clinical Haematology
  23. Enhancer infestation drives tumorigenic activation of inactive B compartment in Epstein-Barr virus-positive nasopharyngeal carcinoma
    Harue Mizokami, Atsushi Okabe, Ruchi Choudhary, Masato Mima, Kenta Saeda, Masaki Fukuyo, Bahityar Rahmutulla, M. Seki, Boon-Cher Goh, Satoru Kondo et al. · 2024 · EBioMedicine
  24. Expression of Plet1 controls interstitial migration of murine small intestinal dendritic cells
    Julien J. Karrich, Mónica Romera‐Hernández, Natalie Papazian, Sharon Veenbergen, Ferry Cornelissen, Patricia Aparicio‐Domingo, Frances Hogg Stenhouse, C. Diana Peddie, Remco Michiel Hoogenboezem, Chelsea W. J. den Hollander et al. · 2018 · European Journal of Immunology
  25. TET2 lesions enhance the aggressiveness of CEBPA-mutant acute myeloid leukemia by rebalancing GATA2 expression
    Elizabeth C. Heyes, Anna S. Wilhelmson, Anne Wenzel, Gabriele Manhart, Thomas Eder, Mikkel Bruhn Schuster, Edwin Rzepa, Sachin Pundhir, Teresa D’Altri, Anne-Katrine Frank et al. · 2023 · Nature Communications
  26. Experimental Validation and Prediction of Super-Enhancers: Advances and Challenges
    Ekaterina V. Kravchuk, German A. Ashniev, Marina G. Gladkova, А. В. Орлов, Anastasiia V. Vasileva, Anna Boldyreva, Alexandr G. Burenin, Artemiy M. Skirda, Petr Ivanovich Nikitin, Natalia N. Orlova · 2023 · Cells
  27. Navigating Transcriptional Coregulator Ensembles to Establish Genetic Networks
    Andrew DeVilbiss, Nobuyuki Tanimura, Skye C McIver, Koichi Ricardo Katsumura, Kirby D. Johnson, Emery H. Bresnick · 2016 · Current topics in developmental biology/Current Topics in Developmental Biology
  28. 3D Genome Organization Influences the Chromosome Translocation Pattern
    Rachel Patton McCord, Adayabalam S. Balajee · 2018 · Advances in experimental medicine and biology
  29. The structural and functional roles of CTCF in the regulation of cell type-specific and human disease-associated super-enhancers
    Ha Youn Shin · 2018 · Genes & Genomics
  30. Ectopia associated MN1 fusions and aberrant activation in myeloid neoplasms with t(12;22)(p13;q12)
    Tong Wang, Xue Chen, Hui Shuang, Jingbo Ni, Ying Yin, Wei Cao, Yan Zhang, Xinyu Wang, Xiaoli Ma, Panxiang Cao et al. · 2020 · Cancer Gene Therapy
  31. Dynamic Interactions of Transcription Factors and Enhancer Reprogramming in Cancer Progression
    Emily Kate Zboril, Hannah Yoo, Lizhen Chen, Zhijie Liu · 2021 · Frontiers in Oncology
  32. Characterization of Structural Variations in the Context of 3D Chromatin Structure.
    Kyukwang Kim, Junghyun Eom, Inkyung Jung · 2019 · PubMed Central
  33. Therapy Resistance and Disease Progression in CML: Mechanistic Links and Therapeutic Strategies
    John Joson Ng, S. Tiong Ong · 2022 · Current Hematologic Malignancy Reports
  34. Three‐dimensional genome structure and function
    Hao Liu, Hsiangyu Tsai, Maoquan Yang, Guozhi Li, Qian Bian, Gang Ding, Dandan Wu, Jiewen Dai · 2023 · MedComm
  35. Altered enhancer-promoter interaction leads to MNX1 expression in pediatric acute myeloid leukemia with t(7;12)(q36;p13)
    Dieter Weichenhan, Anna Riedel, Etienne Sollier, Umut H. Toprak, Joschka Hey, Kersten Breuer, Justyna A. Wierzbińska, Aurore Touzart, Pavlo Lutsik, Marion Bähr et al. · 2024 · Blood Advances
  36. Delta: a new web-based 3D genome visualization and analysis platform
    Bixia Tang, Feifei Li, Jing Li, Wenming Zhao, Zhihua Zhang · 2017 · Bioinformatics
  37. Emerging Epigenetic Therapeutic Targets in Acute Myeloid Leukemia
    Bettina Wingelhofer, Tim C. P. Somervaille · 2019 · Frontiers in Oncology
  38. Quantitative and qualitative impairments in GATA2 and myeloid neoplasms
    Ritsuko Shimizu, Masayuki P. Yamamoto · 2019 · IUBMB Life
  39. Oncogene <i>EVI1</i> drives acute myeloid leukemia via a targetable interaction with CTBP2
    Pastoors, Dorien, Havermans, Marije, Mulet-Lazaro, Roger, Brian, Duncan, Noort, Willy, Grasel, Julius, Hoogenboezem, Remco, Smeenk, Leonie, Demmers, Jeroen A. A., Milsom, Michael D. et al. · 2024 · Science Advances
  40. Spatial 3D genome organization reveals intratumor heterogeneity in primary glioblastoma samples
    Qixuan Wang, Juan Wang, Radhika Mathur, Mark W. Youngblood, Qiushi Jin, Ye Hou, Lena Ann Stasiak, Yu Luan, Hengqiang Zhao, Stephanie Hilz et al. · 2025 · Science Advances
  41. GATA2 deficiency elevates interferon regulatory factor-8 to subvert a progenitor cell differentiation program
    Kirby D. Johnson, Alexandra A. Soukup, Emery H. Bresnick · 2022 · Blood Advances
  42. Super enhancers: Pathogenic roles and potential therapeutic targets for acute myeloid leukemia (AML)
    Ziyang Cao, Yi Shu, Jinxia Wang, Chunxia Wang, Tienan Feng, Yang Li, Jingbo Shao, Lin Zou · 2022 · Genes & Diseases
  43. Sister chromatid–sensitive Hi-C to map the conformation of replicated genomes
    Michael Mitter, Zsuzsanna Takács, Thomas Köcher, Ronald Micura, Christoph C. H. Langer, Daniel W. Gerlich · 2022 · Nature Protocols
  44. EVI1 exerts distinct roles in AML via ERG and cyclin D1 promoting a chemoresistant and immune-suppressive environment
    Yosuke Masamoto, Akira Chiba, Hideaki Mizuno, Toshiya Hino, Hiroki Hayashida, Tomohiko Sato, Masashige Bando, Katsuhiko Shirahige, Mineo Kurokawa · 2022 · Blood Advances
  45. Super-enhancer omics in stem cell
    Hongying Ma, Jian Qu, Zicheng Pang, Jian Luo, Min Yan, Wei-Xin Xu, Haihui Zhuang, Linxin Liu, Qiang Qu · 2024 · Molecular Cancer
  46. Core-binding factor leukemia hijacks the T-cell–prone PU.1 antisense promoter
    Emiel van der Kouwe, Gerwin Heller, Akos Gabor Czibere, John Anto Pulikkan, Christiane Agreiter, Lucio Hernán Castilla, Ruud Delwel, Annalisa Di Ruscio, Alexander K. Ebralidze, M. Forte et al. · 2021 · Blood
  47. Complex chromosomal rearrangements leading to MECOM overexpression are recurrent in myeloid malignancies with various 3q abnormalities
    Carmen Baldazzi, Simona Luatti, Elisa Zuffa, Cristina Papayannidis, Emanuela Ottaviani, Giulia Marzocchi, Gaia Ameli, Maria Antonella Bardi, Laura Bonaldi, Rossella Paolini et al. · 2016 · Genes Chromosomes and Cancer
  48. Making Sense of the Tangle: Insights into Chromatin Folding and Gene Regulation
    Ill-Min Chung, Sarada Ketharnathan, Seung‐Hyun Kim, Muthu Thiruvengadam, Mari Rani, Govindasamy Rajakumar · 2016 · Genes
  49. The multi-CDK inhibitor dinaciclib reverses bromo- and extra-terminal domain (BET) inhibitor resistance in acute myeloid leukemia via inhibition of Wnt/β-catenin signaling
    Alexander R. Marr, Madeline Halpin, Dominique L. Corbin, Yerdanos Asemelash, Steven Sher, Britten K. Gordon, Ethan C. Whipp, Shaneice Renee Mitchell, Bonnie K. Harrington, Shelley J. Orwick et al. · 2024 · Experimental Hematology and Oncology
  50. Epigenetic alterations affecting hematopoietic regulatory networks as drivers of mixed myeloid/lymphoid leukemia
    Roger Mulet‐Lazaro, Stanley van Herk, Margit Nuetzel, Anikó Sijs‐Szabó, Noèlia Díaz, Katherine Kelly, Claudia A. J. Erpelinck-Verschueren, Lucia Schwarzfischer, Hanna Stanewsky, Ute Ackermann et al. · 2024 · Nature Communications
  51. The New Clinicopathologic and Molecular Findings in Myeloid Neoplasms With inv(3)(q21q26)/t(3;3)(q21;q26.2)
    Huan‐You Wang, Hooman H. Rashidi · 2016 · Archives of Pathology & Laboratory Medicine
  52. Genomic Alterations of Non-Coding Regions Underlie Human Cancer: Lessons from T-ALL
    Adrian Rivera-Reyes, Katharina E. Hayer, Craig H. Bassing · 2016 · Trends in Molecular Medicine
  53. Human hematopoiesis: aging and leukemogenic risk
    Emmalee R. Adelman, Maria E. Figueroa · 2020 · Current Opinion in Hematology
  54. Diagnosis of rare subtypes of acute myeloid leukaemia and related neoplasms
    Tracy I. George, Ashish R. Bajel · 2021 · Pathology
  55. Acute myeloid leukemia with t(3;21)(q26.2;q22) developing following low-dose methotrexate therapy for rheumatoid arthritis and expressing two AML1/MDS1/EVI1 fusion proteins: A case report
    Keisuke Tanaka, Gaku Oshikawa, Hiroki Akiyama, Shinya Ishida, Toshikage Nagao, Masahide Yamamoto, Osamu Miura · 2017 · Oncology Letters
  56. Epigenetics in Hematological Malignancies
    Nataly Cruz-Rodríguez, Alba Lucía Cómbita, Jovanny Zabaleta · 2018 · Methods in molecular biology
  57. The role of noncoding mutations in blood cancers
    Sunniyat Rahman, Marc R. Mansour · 2019 · Disease Models & Mechanisms
  58. CRISPR Screening of Transcribed Super-Enhancers Identifies Drivers of Triple-Negative Breast Cancer Progression
    Michael W. Lewis, Caitlin M. King, Kamila Wiśniewska, Matthew J. Regner, Alisha R. Coffey, Michael R. Kelly, Raúl Méndez-Giráldez, Eric S. Davis, Douglas H. Phanstiel, Hector L. Franco · 2024 · Cancer Research
  59. GATA2 rs2335052 Polymorphism Predicts the Survival of Patients with Colorectal Cancer
    Xijuan Liu, Beihai Jiang, Aidong Wang, Jiabo Di, Zaozao Wang, Lei Chen, Xiangqian Su · 2015 · PLoS ONE
  60. Bloody Zebrafish: Novel Methods in Normal and Malignant Hematopoiesis
    Emma de Pater, Eirini Trompouki · 2018 · Frontiers in Cell and Developmental Biology
  61. Structural Variants as a Basis for Targeted Therapies in Hematological Malignancies
    Judith Schütte, Julia Reusch, Cyrus Khandanpour, Christine Eisfeld · 2019 · Frontiers in Oncology
  62. Straight to the Point—The Novel Strategies to Cure Pediatric AML
    Monika Lejman, Izabela Dziatkiewicz, Mateusz Jurek · 2022 · International Journal of Molecular Sciences
  63. Acute Myeloid Leukemia
    Daniel A. Arber · 2018 · Elsevier eBooks
  64. CRISPR-engineered genome editing for the next generation neurological disease modeling
    Weijun Feng, Hai‐Kun Liu, Daisuke Kawauchi · 2017 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  65. The retinoic acid receptor co-factor NRIP1 is uniquely upregulated and represents a therapeutic target in acute myeloid leukemia with chromosome 3q rearrangements
    Sarah Grasedieck, Ariene Cabantog, Liam MacPhee, Junbum Im, Christoph Rueß, Burcu Demir, Nadine Sperb, Frank G. Rücker, Konstanze Döhner, Tobias Herold et al. · 2021 · Haematologica
  66. Transcription factor expression is the main determinant of variability in gene co‐activity
    Lucas van Duin, Robert Krautz, Sarah Rennie, Robin Andersson · 2023 · Molecular Systems Biology
  67. Super-enhancers in tumors: unraveling recent advances in their role in Oncogenesis and the emergence of targeted therapies
    Yu‐meng Ji, Baixue Li, Rongjin Lin, Jing Tang Yuan, Yang Han, Yuping Du, Yang Zhao · 2025 · Journal of Translational Medicine
  68. Epigenomic technologies for precision oncology
    Dieter Weichenhan, Daniel B. Lipka, Pavlo Lutsik, Ashish Goyal, Christoph Plass · 2020 · Seminars in Cancer Biology
  69. The hallmarks of hematopoietic stem cell transplantation for pediatric acute myeloid leukemia
    Eva Rettinger, Dirk Heckl, Brenda E. S. Gibson, Martin G. Sauer, Dominik Turkiewicz, Katharina Kleinschmidt, Krzysztof Kałwak, Dirk Reinhardt, Franco Locatelli, Jan‐Henning Klusmann et al. · 2025 · Leukemia
  70. Evi1 upregulates Fbp1 and supports progression of acute myeloid leukemia through pentose phosphate pathway activation
    Hideaki Mizuno, Junji Koya, Yosuke Masamoto, Yuki Kagoya, Mineo Kurokawa · 2021 · Cancer Science
  71. Decoding Oncofusions: Unveiling Mechanisms, Clinical Impact, and Prospects for Personalized Cancer Therapies
    Kari Salokas, Giovanna Dashi, Markku T Varjosalo · 2023 · Cancers
  72. Biomarkers in acute myeloid leukemia: From state of the art in risk classification to future challenges of RNA editing as disease predictor and therapy target
    Alberto Quattrocchi, Luca Vincenzo Cappelli, Giovanna De Simone, Elisabetta De Marinis, Martina Gentile, Tecla Gasperi, Alessandro Pulsoni, Paolo Ascenzi, Clara Nervi · 2023 · Aspects of Molecular Medicine
  73. Long-range gene regulation and novel therapeutic applications
    Anita van den Heuvel, Ralph Stadhouders, Charlotte Andrieu‐Soler, Frank G. Grosveld, Éric Soler · 2015 · Blood
  74. Proteogenomics Dashboard for the Human Proteome Project
    Daniel Tabas‐Madrid, João Alves-Cruzeiro, Víctor Segura, Elizabeth Guruceaga, Vital Vialás, Gorka Prieto, Carlos García, Fernando José Corrales, Juan Pablo Albar, Alberto Pascual-Montano · 2015 · Journal of Proteome Research
  75. 2016 Revision to the WHO classification of acute myeloid leukemia
    Ming Hong, Guangsheng He · 2017 · Journal of Translational Internal Medicine
  76. Rapid progression to AML in a patient with germline GATA2 mutation and acquired NRAS Q61K mutation
    Lisa J. McReynolds, Yubo Zhang, Yanqin Yang, Jingrong Tang, Matthew P. Mulè, Amy P. Hsu, Danielle Michelle Townsley, Robert R. West, Jun Zhu, Dennis D. Hickstein et al. · 2019 · Leukemia Research Reports
  77. A Cohesin-Mediated Intrachromosomal Loop Drives Oncogenic ROR lncRNA to Accelerate Tumorigenesis
    Jiayan Fan, Yangfan Xu, Xuyang Wen, Shengfang Ge, Renbing Jia, He Zhang, Xianqun Fan · 2019 · Molecular Therapy
  78. Modeling three-dimensional genomic organization in evolution and pathogenesis
    Alon Diament, Tamir Tuller · 2018 · Seminars in Cell and Developmental Biology
  79. EVI1-mediated Programming of Normal and Malignant Hematopoiesis
    Susanne Lux, Michael D. Milsom · 2023 · HemaSphere
  80. Preclinical efficacy of targeting epigenetic mechanisms in AML with 3q26 lesions and EVI1 overexpression
    Christine E. Birdwell, Warren C. Fiskus, Tapan Mahendra Kadia, Christopher Peter Mill, Koji Sasaki, Naval Guastad Daver, Courtney Denton Dinardo, Naveen Pemmaraju, Gautam M. Borthakur, John A. Davis et al. · 2023 · Leukemia
  81. CEBPA repression by MECOM blocks differentiation to drive aggressive leukemias
    Travis J. Fleming, Mateusz Antoszewski, Sander Lambo, Michael C. Gundry, Riccardo Piussi, Lara Wahlster, Sanjana B. Shah, Fiona E. Reed, Kevin D. Dong, João A. Paulo et al. · 2025 · Blood
  82. The present and future of genome editing in cancer research
    Xiaoyi Li, Riga Wu, Andrea Ventura · 2016 · Human Genetics
  83. BloodChIP Xtra: an expanded database of comparative genome-wide transcription factor binding and gene-expression profiles in healthy human stem/progenitor subsets and leukemic cells
    Julie A.I. Thoms, Forrest C. Koch, Alireza Raei, Shruthi Subramanian, Jason W.H. Wong, Fatemeh Vafaee, John E. Pimanda · 2023 · Nucleic Acids Research
  84. Predictive value of high EVI1 expression in AML patients undergoing myeloablative allogeneic hematopoietic stem cell transplantation in first CR
    X He, Qianqian Wang, Jiepeng Cen, Huiying Qiu, Aining Sun, Simiao Chen, Depei Wu · 2016 · Bone Marrow Transplantation
  85. Phenotypic interpretation of complex chromosomal rearrangements informed by nucleotide-level resolution and structural organization of chromatin
    Cinthya J. Zepeda‐Mendoza, Alexandra G Bardon, Tammy Kammin, David J. Harris, Helen Cox, Claire E. Redin, Zehra Ordulu, Michael E. Talkowski, Cynthia Casson Morton · 2018 · European Journal of Human Genetics
  86. New biomarkers in non-Hodgkin lymphoma and acute leukemias
    Benjamín Rubio-Jurado, Lluvia Sugey Sosa-Quintero, Ivette Lenina Carrasco-Martinez, Armando Norato-Delgado, Eduardo García-Luna, Sandra Guzmán-Silahua, Carlos Riebeling‐Navarro, Arnulfo Hernán Nava-Zavala · 2020 · Advances in clinical chemistry
  87. Molecular landscape in acute myeloid leukemia: where do we stand in 2016
    Karam Al-Issa, Nazha Aziz · 2016 · Cancer Biology and Medicine
  88. Enhancer rewiring in tumors: an opportunity for therapeutic intervention
    Laia Richart, François‐Clément Bidard, Raphaël Margueron · 2021 · Oncogene
  89. The Genetic Makeup of Myeloproliferative Neoplasms: Role of Germline Variants in Defining Disease Risk, Phenotypic Diversity and Outcome
    Elena Masselli, Giulia Pozzi, Cecilia Carubbi, Marco Vitale · 2021 · Cells
  90. Detailed Regulatory Interaction Map of the Human Heart Facilitates Gene Discovery for Cardiovascular Disease
    Valerio Bianchi, Geert Geeven, Nathan R. Tucker, Catharina R.E. Hilvering, Amelia Weber Hall, Carolina Roselli, Matthew C. Hill, James F. Martin, Kenneth B. Margulies, Patrick T. Ellinor et al. · 2019 · SSRN Electronic Journal
  91. Induction of functional neutrophils from mouse fibroblasts by thymidine through enhancement of Tet3 activity
    Buqing Ye, Liuliu Yang, Benyu Liu, Nian Liu, Dongdong Fan, Huimu Li, Lei Sun, Ying Du, Shuo Wang, Yong Tian et al. · 2022 · Cellular and Molecular Immunology
  92. Oncogenic Enhancers in Leukemia
    Roger Mulet‐Lazaro, Ruud Delwel · 2024 · Blood Cancer Discovery
  93. 3q26/ EVI1 rearrangement in myelodysplastic/myeloproliferative neoplasms: An early event associated with a poor prognosis
    Zhihong Hu, Shimin Hu, Changsheng Ji, Zhenya Tang, Beenu Thakral, Sanam Loghavi, Leonard Jeffrey Medeiros, Wei Wang · 2017 · Leukemia Research
  94. Pan-cancer analysis of somatic mutations and epigenetic alterations in insulated neighbourhood boundaries
    Pietro Pinoli, Eirini Stamoulakatou, An-phi Nguyen, María Rodríguez Martínez, Stefano Ceri · 2020 · PLoS ONE
  95. From FISH to Hi-C: The Chromatin Architecture of the Chromosomal Region 7q36.3, Frequently Rearranged in Leukemic Cells, Is Evolutionary Conserved
    Gulino, Gesualda M., Bruno, Francesca, Sturiale, Valentina, Brancato, Desiree, Ragusa, Denise, Tosi, Sabrina, Saccone, Salvatore, Federico, Concetta · 2021 · International Journal of Molecular Sciences
  96. An erythrocyte-centric view on the MFSD2B sphingosine-1-phosphate transporter
    Shahrooz Ghaderi, Bodo Levkau · 2023 · Pharmacology & Therapeutics
  97. From Reductionism to Holism: Toward a More Complete View of Development Through Genome Engineering
    Rebecca K. Delker, Richard S. Mann · 2017 · Advances in experimental medicine and biology
  98. Targeting transcriptional machinery to inhibit enhancer-driven gene expression in heart failure
    Rachel A Minerath, Duane D. Hall, Chad Eric Grueter · 2019 · Heart Failure Reviews
  99. Advances in Acute Myeloid Leukemia Genomics, where do we stand in 2018?
    Yazan F. Madanat, Matt E Kalaycio, Aziz Nazha · 2019 · Acta Medica Academica
  100. The evolution of leukaemia from pre‐leukaemic and leukaemic stem cells
    Liran I. Shlush, Tzah Feldman · 2021 · Journal of Internal Medicine